Shahrokh; Zahra
Patent Applications and Registrations
Patent applications and USPTO patent grants for Shahrokh; Zahra.The latest application filed is for "methods and compositions for cns delivery of heparan n-sulfatase".
Company Profile
13.40.53
- Shahrokh; Zahra - Weston MA
- SHAHROKH; Zahra - Newton MA
- Shahrokh; Zahra - Cambridge MA
- Shahrokh; Zahra - San Francisco CA US
Patent Activity
| Patent | Date |
|---|---|
| Methods And Compositions For Cns Delivery Of Heparan N-sulfatase App 20220133862 - Natoli; Farah ; et al. | 2022-05-05 |
| Stable Anti-OSMR Antibody Formulation App 20220062414 - Manning; Mark Cornell ; et al. | 2022-03-03 |
| Methods and compositions for CNS delivery of iduronate-2-sulfatase Grant 11,260,112 - Zhu , et al. March 1, 2 | 2022-03-01 |
| Anti-IL-6 Antibody Formulation App 20220040301 - Zhu; GaoZhong ; et al. | 2022-02-10 |
| Stable anti-OSMR antibody formulation Grant 11,141,479 - Manning , et al. October 12, 2 | 2021-10-12 |
| Methods and compositions for CNS delivery of heparan n-sulfatase Grant 11,065,308 - Natoli , et al. July 20, 2 | 2021-07-20 |
| Phthalocyanine Dye Conjugate Compositions App 20210205455 - MANIBUSAN; Anthony ; et al. | 2021-07-08 |
| Methods and Compositions for CNS Delivery of Arylsulfatase A App 20200405825 - Salamat-Miller; Nazila ; et al. | 2020-12-31 |
| Stable Formulations For Cns Delivery Of Arylsulfatase A App 20200237883 - Salamat-Miller; Nazila ; et al. | 2020-07-30 |
| Stable formulations for CNS delivery of arylsulfatase A Grant 10,660,944 - Salamat-Miller , et al. | 2020-05-26 |
| Methods and compositions for CNS delivery of arylsulfatase A Grant 10,646,554 - Salamat-Miller , et al. | 2020-05-12 |
| Cns Delivery Of Therapeutic Agents App 20200113981 - Calias; Pericles ; et al. | 2020-04-16 |
| Stable Anti-OSMR Antibody Formulation App 20200061188 - Manning; Mark Cornell ; et al. | 2020-02-27 |
| Methods And Compositions For Cns Delivery Of Iduronate-2-sulfatase App 20200046810 - Zhu; Gaozhong ; et al. | 2020-02-13 |
| Stable anti-OSMR antibody formulation Grant 10,493,149 - Manning , et al. De | 2019-12-03 |
| CNS delivery of therapeutic agents Grant 10,456,454 - Calias , et al. Oc | 2019-10-29 |
| Stable anti-OSMR antibody formulation Grant 10,391,170 - Manning , et al. A | 2019-08-27 |
| Methods And Compositions For Cns Delivery Of Heparan N-sulfatase App 20190183984 - Natoli; Farah ; et al. | 2019-06-20 |
| Stable Formulations For Cns Delivery Of Arylsulfatase A App 20190125841 - Salamat-Miller; Nazila ; et al. | 2019-05-02 |
| Stable Anti-osmr Antibody Formulation App 20190054169 - Manning; Mark Cornell ; et al. | 2019-02-21 |
| Stable Anti-osmr Antibody Formulation App 20180333489 - Manning; Mark Cornell ; et al. | 2018-11-22 |
| A Method For Development Of Recombinant Proteins With Fingerprint Like Similarity To The Reference Product App 20180180626 - Leszczyniecka; Magdalena ; et al. | 2018-06-28 |
| Stabilized Compositions Of Proteins Having A Free Thiol Moiety App 20180104314 - ZHU; Gaozhong ; et al. | 2018-04-19 |
| Methods And Compositions For Cns Delivery Of Arylsulfatase A App 20180071212 - Salamat-Miller; Nazila ; et al. | 2018-03-15 |
| Methods and compositions for CNS delivery of arylsulfatase A Grant 9,770,410 - Salamat-Miller , et al. September 26, 2 | 2017-09-26 |
| Stabilized compositions of proteins having a free thiol moiety Grant 9,694,057 - Zhu , et al. July 4, 2 | 2017-07-04 |
| Methods And Compositions For Cns Delivery Of Heparan N-sulfatase App 20170042977 - Natoli; Farah ; et al. | 2017-02-16 |
| Cns Delivery Of Therapeutic Agents App 20170042978 - Calias; Pericles ; et al. | 2017-02-16 |
| Methods And Compositions For Cns Delivery Of Iduronate-2-sulfatase App 20160158324 - Zhu; Gaozhong ; et al. | 2016-06-09 |
| Methods and compositions for CNS delivery of heparan N-sulfatase Grant 9,320,711 - Natoli , et al. April 26, 2 | 2016-04-26 |
| CNS delivery of therapeutic agents Grant 9,283,181 - Calias , et al. March 15, 2 | 2016-03-15 |
| Characterization Of Mrna Molecules App 20160032273 - SHAHROKH; Zahra ; et al. | 2016-02-04 |
| Analysis Of Mrna Heterogeneity And Stability App 20160017313 - SPIVAK; Vlad Boris ; et al. | 2016-01-21 |
| Methods and compositions for CNS delivery of iduronate-2-sulfatase Grant 9,220,677 - Zhu , et al. December 29, 2 | 2015-12-29 |
| Subcutaneous Administration Of Alpha-galactosidase A App 20150306187 - Sturk; Lisa Marie ; et al. | 2015-10-29 |
| Stabilized Compositions Of Proteins Having A Free Thiol Moiety App 20150283216 - ZHU; Gaozhong ; et al. | 2015-10-08 |
| Stabilized compositions of proteins having a free thiol moiety Grant 9,072,785 - Zhu , et al. July 7, 2 | 2015-07-07 |
| Stable Formulations For Cns Delivery Of Arylsulfatase A App 20140377244 - Salamat-Miller; Nazila ; et al. | 2014-12-25 |
| Methods And Compositions For Cns Delivery Of Iduronate-2-sulfatase App 20140271598 - Zhu; Gaozhong ; et al. | 2014-09-18 |
| Stabilized Compositions Of Proteins Having A Free Thiol Moiety App 20140219987 - Zhu; Gaozhong ; et al. | 2014-08-07 |
| Stabilized compositions of proteins having a free thiol moeity Grant 8,673,298 - Zhu , et al. March 18, 2 | 2014-03-18 |
| Methods of binding TNF-.alpha. using anti-TNF-.alpha. antibody fragment-polymer conjugates Grant 8,652,468 - Hsei , et al. February 18, 2 | 2014-02-18 |
| Subcutaneous Administration Of Alpha-galactosidase A App 20140037612 - Sturk; Lisa Marie ; et al. | 2014-02-06 |
| Methods And Compositions For Cns Delivery Of B-galactocerebrosidase App 20130295071 - Salamat-Miller; Nazila ; et al. | 2013-11-07 |
| Methods and compositions for CNS delivery of iduronate-2-sulfatase Grant 8,545,837 - Zhu , et al. October 1, 2 | 2013-10-01 |
| Apo-2 ligand/trail formulations Grant 8,470,969 - Flores , et al. June 25, 2 | 2013-06-25 |
| Methods of binding TNF-alpha using Anti-TNF-alpha antibody fragment-polymer conjugates App 20130084302 - Hsei; Vanessa ; et al. | 2013-04-04 |
| Antibody fragment-polymer conjugates and uses of same Grant 8,147,830 - Hsei , et al. April 3, 2 | 2012-04-03 |
| Methods for making Apo-2 Ligand using divalent metal ions App 20120077740 - Ashkenazi; Avi J. ; et al. | 2012-03-29 |
| Methods And Compositions For Cns Delivery Of Heparan N-sulfatase App 20120014936 - Natoli; Farah ; et al. | 2012-01-19 |
| Methods And Compositions For Cns Delivery Of Arylsulfatase A App 20120009171 - Salamat-Miller; Nazila ; et al. | 2012-01-12 |
| Cns Delivery Of Therapeutic Agents App 20120003202 - Calias; Pericles ; et al. | 2012-01-05 |
| Methods And Compositions For Cns Delivery Of Iduronate-2-sulfatase App 20110318323 - Zhu; Gaozhong ; et al. | 2011-12-29 |
| Methods And Compositions For Cns Delivery Of B-galactocerebrosidase App 20110318324 - Salamat-Miller; Nazila ; et al. | 2011-12-29 |
| Apo-2 Ligand/trail Formulations App 20110269947 - Flores; Heather ; et al. | 2011-11-03 |
| APO-2 ligand/trail formulations App 20110245185 - Flores; Heather ; et al. | 2011-10-06 |
| Antibody Fragment-polymer Conjugates And Uses Of Same App 20110104185 - Hsei; Vanessa ; et al. | 2011-05-05 |
| Stabilized Compositions Of Proteins Having A Free Thiol Moiety App 20110091414 - Zhu; Gaozhong ; et al. | 2011-04-21 |
| Method Of Purifying Apo-2 Ligand/trail Usin Crystallisation The Cold App 20110054153 - Flores; Heather ; et al. | 2011-03-03 |
| Methods for making Apo-2 ligand using divalent metal ions Grant 7,855,066 - Ashkenazi , et al. December 21, 2 | 2010-12-21 |
| Apo-2 ligand/trail formulations Grant 7,842,668 - Flores , et al. November 30, 2 | 2010-11-30 |
| Antibody fragment-polymer conjugates and uses of same Grant 7,842,789 - Hsei , et al. November 30, 2 | 2010-11-30 |
| Subcutaneous Administration Of Alpha-galactosidase A App 20100291060 - Sturk; Lisa Marie ; et al. | 2010-11-18 |
| Stabilized compositions of proteins having a free thiol moiety Grant 7,833,766 - Zhu , et al. November 16, 2 | 2010-11-16 |
| APO-2 ligand/trail formulations Grant 7,741,285 - Flores , et al. June 22, 2 | 2010-06-22 |
| ApO2 ligand/TRAIL formulations Grant 7,741,282 - Lin , et al. June 22, 2 | 2010-06-22 |
| Antibody fragment-polymer conjugates and uses of same App 20090098147 - Hsei; Vanessa ; et al. | 2009-04-16 |
| Antibody fragment-polymer conjugates and uses of same Grant 7,507,405 - Hsei , et al. March 24, 2 | 2009-03-24 |
| Stabilized Compositions Of Proteins Having A Free Thiol Moiety App 20070197439 - Zhu; Gaozhong ; et al. | 2007-08-23 |
| Methods for making Apo-2 ligand using divalent metal ions App 20070161564 - Ashkenazi; Avi J. ; et al. | 2007-07-12 |
| Antibody fragment-polymer conjugates and uses of same Grant 7,214,776 - Hsei , et al. May 8, 2 | 2007-05-08 |
| Antibody fragment-polymer conjugates and uses of same App 20070048219 - Hsei; Vanessa ; et al. | 2007-03-01 |
| Antibody fragment-polymer conjugates and uses of same Grant 7,122,636 - Hsei , et al. October 17, 2 | 2006-10-17 |
| Antibody fragment-polymer conjugates and uses of same App 20060083683 - Hsei; Vanessa ; et al. | 2006-04-20 |
| Antibody fragment-peg conjugates Grant 7,005,504 - Hsei , et al. February 28, 2 | 2006-02-28 |
| Apo-2 ligand/trail formulations App 20060009387 - Flores; Heather ; et al. | 2006-01-12 |
| Antibody formulation App 20050158316 - Lam, Xanthe M. ; et al. | 2005-07-21 |
| Apo2 ligand/trail formulations App 20050080006 - Lin, Tanya P. ; et al. | 2005-04-14 |
| Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies Grant 6,870,033 - Hsei , et al. March 22, 2 | 2005-03-22 |
| Apo-2 ligand/trail formulations App 20050020498 - Flores, Heather ; et al. | 2005-01-27 |
| Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies App 20030021790 - Hsei, Vanessa ; et al. | 2003-01-30 |
| Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates Grant 6,468,532 - Hsei , et al. October 22, 2 | 2002-10-22 |
| Methods of treating inflammatory disease with anti-IL-8 antibody fragment-polymer conjugates Grant 6,458,355 - Hsei , et al. October 1, 2 | 2002-10-01 |
| Antibody formulation Grant 6,171,586 - Lam , et al. January 9, 2 | 2001-01-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 